iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
AASLD Selected Highlights - HCV Elimination, Screening, Treatment
 
 
  AASLD: GLOBAL PREVALENCE OF HEPATITIS C VIRUS IN WOMEN OF CHILDBEARING AGE IN 2019: A MODELING STUDY - (12/21/20)
 
HBV & HCV & Accelerated Senescence: premature aging - (12/18/20)
 
Hepatitis A, B and C in New York City: 2019 Annual Report - (12/16/20)
 
New York State Department of Health Hepatitis B and C Annual Report 2018 - (12/18/20)
 
 Universal Screening Real Implementation is Required for HCV Elimination & Reduced Mortality
 
 AASLD: All Adult HCV Testing Global and US Implementation - (11/16/20) John Ward
 
AASLD: Determining Feasibility of Hepatitis C Elimination in the United States Using a Simulation Model - (11/16/20)
 
AASLD: Country and WHO Regional Trends for Hepatitis C Virus (HCV) Mortality, 1990-2019: An Analysis of the Global Burden of Disease (GBD) Study - (11/17/20)
 
---------------------------------
 
AASLD: Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes - (11/13/20)
 
AASLD: The risk of HCV recurrence in HCV infected patients treated with DAA after achieving a sustained virological response: a comprehensive analysis - (11/13/20)
 
AASLD: AUTOMATED VIRAL HEPATITIS (HCV AND HBV) SCREENING: LESSONS ON EXPANSION & SUSTAINABILITY AMIDST THE COVID-19 PANDEMIC - (12/21/20) NJ
 
AASLD: ELIMINATING HEPATITIS C: A COMPREHENSIVE PROGRAM OF DIGITAL CASE FINDING AND LINKAGE TO CARE ACROSS A LARGE URBAN HEALTHCARE SYSTEM - (11/13/20) NYC
 
AASLD: Early phase implementation of routine opt out hepatitis C testing in the Philadelphia jail system - (11/28/20) Philadelphia
 
AASLD: Provision of Hepatitis C Care in a Federally Qualified Health Center during the COVID-19 Pandemic - (11/13/20) Philadelphia
 
AASLD: A hospital free of Hepatitis C: Hepatitis C virus screening program in an Emergency Department of a tertiary hospital of a high-income country. (Preliminary results) - (11/16/20)
 
AASLD: Treatment As Prevention: Addressing HCV in Persons Who Inject Drugs (PWID) - (11/28/20)
 
AASLD: POINT-OF-CARE HEPATITIS C TESTING AND TREATING STRATEGY IN PEOPLE WHO INJECT DRUGS IN HARM REDUCTION AND ADDICTION CENTERS FOR HEPATITIS C ELIMINATION (11/19/20)
 
AASLD: Active Drug Use Is Not Associated with Treatment Failure Among PWID Patients With Variable Adherence to HCV Treatment - (11/16/20)
 
AASLD: Variable Adherence To HCV Treatment Among People Who Inject Drugs Treated with 8 Versus 12 Weeks of Antiviral Therapy Resulted In High Rates of SVR - (11/16/20)
 
AASLD: Real-World Outcomes in Patients With Chronic Hepatitis C Virus Infection and Substance Use Disorders Treated With Glecaprevir/Pibrentasvir for 8 Weeks: A Pooled Analysis of Multinational Postmarketing Observational Studies (11/19/20)
 
AASLD: HCV elimination in homeless patients is possible: a pooled real-world analysis of homeless patients with HCV treated with sofosbuvir/velpatasvir (SOF/VEL) for 12 weeks - (11/13/20)
 
AASLD: The value of sofosbuvir/velpatasvir (SOF/VEL) as a pangenotypic and panfibrotic HCV treatment in implementing a test-and-treat strategy in prisons: real-world care management from 6 countries - (11/13/20)
 
AASLD: A Multisite Randomized Pragmatic Trial of Patient-Centered Models of Hepatitis C Treatment for People Who Inject Drugs: The HERO Study - Hepatitis C Real Options - (11/16/20)
 
AASLD: The "Keep It Simple and Safe" Approach to HCV Treatment: Primary Outcomes from the ACTG A5360 (MINMON) Study (11/19/20)
 
AASLD: Low adherence to infant HCV testing guidelines among pregnant women with HCV cirrhosis - (11/16/20)
 
AASLD: COST-EFFECTIVENESS OF ANTENATAL RESCREENING AMONG PREGNANT WOMEN FOR HEPATITIS C IN THE UNITED STATES (11/20/20)
 
AASLD: State Policies Limiting Progress Towards HCV Elimination in the U.S. (11/20/20)
 
AASLD: Effectiveness of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic HCV infection and mental health disorders: real-world care management from 8 countries - (11/13/20)

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org